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Abstract A protein-tyrosine phosphatase LC-PTP is preferen- 
tially expressed in hematopoietic ells and is an early response 
gene in lymphokine stimulated cells. Here, we found the LC-PTP 
mRNA induction by IL-2 was markedly inhibited by several tyro- 
sine kinase inhibitors. The induction required both the acidic and 
serine-rich regions of the IL-2 receptor /3 chain (IL-2RI~) in 
mouse IL-3-dependent pro-B BAF-B03 transfectants. This is 
strikingly different from the induction of c-myc gene expression, 
which requires the serine-rich region alone. In addition, overex- 
pression of activated-Lck or -Raf kinases resulted in augmented 
LC-PTP mRNA expression in myeloid cell line 32D transfec- 
tants. Considering the previous findings that the acidic region of 
the IL-2RI~ is responsible for association with Lck and activation 
of Raf kinase, IL-2-induced expression of LC-PTP mRNA may 
be primarily transduced through a Lck-Raf mediated signaling 
pathway. 
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1. Introduction 
induction of c-myc gene, whereas an 'acidic' region is responsi- 
ble for its physical association with p56 ~ck and leads to the 
induction of c-Jbs/c-jun genes [7]. 
Protein-tyrosine phosphatases (PTPs) may also be involved 
in IL-2-signaling by removing phosphates from the phosphoty- 
rosyl groups on target proteins. For the most part, however, 
the role of PTPs in cytokine signal transduction still remains 
enigmatic, Recently, we and others cloned a cDNA encoding 
a non-receptor LC-PTP (also called by HePTP) [8-10] which 
is preferentially expressed in T-cells. We have previously shown 
that LC-PTP gene has 11 exons [11] and is classified as an early 
response gene in that LC-PTP mRNA induction by lymphoki- 
nes does not require new protein synthesis [12]. The expression 
pattern of LC-PTP gene leads us to investigate the possible 
signaling pathway leading to its expression. We report here that 
the induction of LC-PTP mRNA expression was inhibited by 
PTK inhibitors. The induction requires both the cytoplasmic 
serine-rich and acidic regions of the IL-2Rfl. In addition, we 
show that the overexpression f the constitutively active form 
of Lck or Raf kinase results in the augmented expression of 
LC-PTP mRNA, suggesting the involvement of the LcldRaf 
mediated signaling in the LC-PTP mRNA induction. 
Many growth factor receptors possess an intrinsic protein 
tyrosine kinase (PTK) region [1] or a region(s) responsible for 
coupling with a non-receptor PTK, such as those of the Src 
family. For example, p56~Ckassociates with CD4/CD8 in T-cells, 
p59 fy" with the T-cell receptor complex, and p56 lyn with the 
B-cell antigen receptor [2-4]. Proliferation of T-cells is triggered 
by the interaction of IL-2 with IL-2 receptor (IL-2R) which 
consists of three distinct subunits, IL-2R~, IL-2Rfl, and 
IL-2Rz [5]. Structure-function a alysis of the IL-2Rfl chain 
(IL-2Rfl) has revealed that at least two distinct cytoplasmic 
regions are involved in IL-2-induced cellular signaling [6]. A 
'serine- rich' region within the cytoplasmic domain of IL-2Rfl 
is crucial for IL-2-induced mitotic signaling and leads to the 
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2. Materials and methods 
2.1. Reagents and cell culture 
Murine pro-B cell BAF-B03 and myeloid 32D transfectants were 
IL-3-dependent, and were maintained in RPMI-1640 medium (Gibco, 
Grand Island, NY) with 10% fetal calf serum (FCS) and 10% WEHI-3B 
conditioned medium (as a source of murine IL-3). BAF-B03-derived 
transfectants, which express the wild type of IL-2Rfl (F7), mutant 
I L-2R fl lacking the acidic region (A 15), or mutant IL-2Rfl lacking the 
serine-rich region ($25) were established as described previously [6]. For 
factor-deprivation experiments, cells were washed twice, and resus- 
pended in a medium without he factor for 18-24 h. Following 400 U/ml 
of IL-2 (kindly provided by Shionogi Chemical Pharmacy, Japan) or 
IL-3 stimulation, RNA expression levels were analyzed by Northern 
blot analysis. To evaluate the effects of various inhibitors, 1 #M KN-62 
(Seikagaku Co.); a CaZ+/CaM kinase II inhibitor [13], 30/IM H-89 
(Seikagaku Co.); a cAMP-dependent protein kinase inhibitor [14], 100 
pM tyrphostin ST638 (kindly provided by Kanebuchi Chemical Co., 
Japan) and 100 pM genistein; protein tyrosine kinase specific inhibitors 
[15,16], 2.5 nM FK506 (kindly provided by Fujisawa Chemical Co.); 
a serine/threonine phosphatase PP2B inhibitor [17], and 10 mg/ml of 
cycloheximide (Sigma); a protein synthesis inhibitor were added into 
the culture 0.5 h before IL-2 stimulation. 
2.2. Northern blot analysis' 
Total RNAs were extracted from BAF-B03 and 32D transfectants 
by the guanidium/CsC1 procedure. Ten ktg of the total RNAs were 
separated by t% agarose formaldehyde gel electrophoresis and were 
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transferred onto nitrocellulose filters. The filters were hybridized with 
32P-labeled cDNA fragments as probes; the 0.6-kb 5' region of the 
human LC-PTP cDNA clone [8], and the 2.2-kb human full-length 
c-myc DNA [18]. The hybridization and washing condition were per- 
formed as described previously [8]. The intensities of the respective 
bands were assessed by the Bio-lmaging Analyzer (Fuji Photo Film 
Co., model BAS-2000). 
2.3. Western blot analysis 
Preparation of anti-LC-PTP polyclonal antibody isdescribed previ- 
ously [12]. BAF-B03 cells expressing the IL-2Rfl, F7 cells were washed 
with cold phosphate-buffered saline (PBS) and lysed in 100 ,ul of a 
buffer containing 100 mM NaCI, 2 mM EDTA, 10 mM sodium ortho- 
vanadate, 1 mM PMSF, 1% NP-40 and 50 mM Tris (pH 7.2). The 
protein concentrations of the lysates were analyzed by the Protein 
Assay kit (BioRad) and each lysate was subjected to SDS-PAGE, fol- 
lowed by electrophoretical transfer onto Immobilon (Millipore). The 
blots were incubated with blocking buffer containing 3% BSA, 10 mM 
Tris (pH 8.2), 140 mM NaCI, and 0.01% NAN3. Then, they were incu- 
bated with 2 pg/ml of anti-LC-PTP antibody for 2 h in washing solution 
(150 mM NaC1, 10 mM Tris (pH 7.5) and 0.01% Tween 20) with 2% 
FCS, and washed several times in washing solution, following by an 
additional 1 h of incubation with peroxidase-conjugated anti-rabbit 
IgG antibody (Amersham). The blots were developed by a standard 
ECL method. 
3. Results 
3.1. IL-2 upregulates LC-PTP mRNA and its protein levels in 
F7 cells 
F7 cells are an IL-2Rfl-expressing transfectant of the murine 
IL-3-dependent pro-B cell clone BAF-B03, which expresses 
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endogenous mouse IL-2R~ and IL-2Ry chains at relatively 
high levels, but normally lack IL-2Rfl and thus fail to respond 
to IL-2. The F7 transfectant expressing the human IL-2Rfl 
(wild-type) binds IL-2 with high affinity and proliferates in 
response to IL-2 [6]. Although LC-PTP mRNA was not in- 
duced by IL-2 stimulation in BAF-B03 (data not shown), the 
induction was clearly seen in F7 clone (Fig. 1A). The induction 
was detectable within 3 h and peaked at 9 h after IL-2 stimula- 
tion, revealing a similar kinetics of LC-PTP mRNA induction 
to IL-2-stimulated human T-cell line ILT-Mat, as described 
previously [12]. We performed Western blot analysis to deter- 
mine whether the IL-2-induced increases in LC-PTP mRNA 
levels in F7 cells were associated with increases in the level of 
LC-PTP protein. The polyclonal antibody to LC-PTP protein 
that we previously generated [12], recognized a major band with 
molecular mass of 40-kDa, and the intensity of the major band 
was increased by approximately 2-fold in F7 cells at 12 h after 
IL-2 stimulation (Fig. 1B), indicating that LC-PTP mRNA 
induction leads to elevations in LC-PTP protein levels. 
3.2. Two functional domains of lL-2Rfl are required for LC-PTP 
mRNA induction 
To identify the region(s) of IL-2Rfl responsible for the 
LC-PTP mRNA induction, we employed two BAF-B03-de- 
rived transfectants expressing the respective mutant IL-2Rfl. 
A I5 cells express IL-2Rfl lacking the acidic region and $25 cells 
express IL-2Rfl lacking the serine-rich region [6]. IL-2 stimula- 
tion of both clones failed to induce LC-PTP mRNA expression, 
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Fig. 1. Time course of LC-PTP mRNA induction and LC-PTP protein by IL-2 in BAF-B03 F7 transfectants. (A) BAF-B03 transfectants (F7) were 
treated with IL-2 (400 U/ml) and total RNA was extracted from the cells at the indicated times. Northern blot analysis was performed by hybridizing 
with a 32P-labeled LC-PTP probe. The positions of ribosomal RNAs, which are shown for relative amounts of total RNA loaded and their quality, 
are indicated to the right of the blot. (B) Cell lysates from control and IL-2-treated F7 cells (6 h and 24 h) were normalized for the amount (75 pg/lane) 
of protein, and fractionated by 10% SDS-gel electrophoresis. LC-PTP protein was subsequently detected by immunoblotting with a polyclonal 
anti-LC-PTP antibody (2 pg/ml). 
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Fig. 2. LC-PTP mRNA induction and cellular proliferation by IL-2 in BAF-B03 transfectants. (A) BAF-B03 transfectants (F7, A15, and $25) were 
treated with IL-2, and their LC-PTP mRNA and c-myc mRNA expressions were analyzed by Northern blots. Ribosomal RNAs are shown for relative 
amounts of total RNA loaded and their quality. (B) F7, AI5 and $25 transfectants grown in control medium (open) or in medium containing IL-2 
(closed) were counted every day. The mean number of the cells from three independent experiments was plotted against the number of days. Standard 
error values are indicated. 
whereas timulation of A 15 cells induced c-myc gene expression 
(Fig. 2A). These findings therefore, indicate that the induction 
of LC-PTP mRNA requires both the acidic and serine-rich 
regions of the IL-2Rfl. When the BAF-B03 transfectants were 
exposed to IL-2, AI5 and F7 cells exhibited good proliferative 
response, while $25 cells did not respond at all. The cellular 
growth curve of AI5 ceils was similar to that of F7 cells, but 
the increase of cell numbers in A15 cells was slightly delayed 
(Fig. 2B). 
3.3. IL-2-induced LC-PTP gene expression requires tyrosine 
phosphorylation 
In order to explore the signaling pathways involved in the 
IL-2-mediated LC-PTP mRNA induction, F7 cells were de- 
prived of IL-3 for 24 h, exposed to various pharmacological 
reagents for 0.5 h and then stimulated by IL-2. Consistent with 
our previous observations [12], the IL-2-mediated induction of 
LC-PTP mRNA was not blocked by the addition of CHX 
(Fig. 3), indicating that protein synthesis is not necessarily 
required. The induction of LC-PTP expression by IL-2 was 
inhibited almost completely by the tyrosine kinase inhibitors 
ST638 and genistein, but was not affected by other protein 
kinase inhibitors including KN-62 and H-89, or by the PP2B 
inhibitor FK506 (Fig. 3). These data suggest that tyrosine phos- 
phorylation is required for LC-PTP gene expression in IL-2- 
stimulated F7 cells. In addition, these pharmacological reagents 
produced similar effects on c-myc gene expression, although the 
effects of ST638 showed different sensitivity to ST638 (Fig. 3). 
3.4. IL-3-induced LC-PTP gene expression also requires 
tyrosine phosphorylation 
To examine whether the signaling pathways involved in 
LC-PTP gene expression utilizes a common pathway shared by 
IL-2 and IL-3, we analyzed LC-PTP mRNA expression i  F7 
cells after IL-3 stimulation. LC-PTP gene expression was 
clearly induced at 3 h after IL-3 stimulation (Fig. 4). We also 
examined the effects of the tyrosine kinase inhibitors, ST638 
and genistein. As seen when IL-2 was employed, IL-3-induced 
LC-PTP mRNA expression also required activation of tyrosine 
kinase(s), since the induction was completely inhibited by these 
tyrosine kinase inhibitors (Fig. 4). 
3.5. Augmented expression of LC-PTP mRNA in Lck- and 
Raf-transfected 32D cells 
Previously, it has been shown that the IL-3-dependent my- 
eloid progenitor cell clone 32D.3 cells proliferate in response 
to IL-2 when the IL-2Rfl was introduced into the cells by gene 
transfer methods, implying that 32D cells utilized similar intra- 
cellular signaling machinery to IL-2-dependent T-cells and 
IL-3-dependent BAF-B03 cells. We already established 32D 
transfectants, which express constitutively active forms of Lck 
or Raf kinases [19,20]. In order to clarify the involvement of 
these kinases in LC-PTP mRNA induction, the relative steady- 
state levels of LC-PTP mRNA was analyzed in these transfec- 
tants following deprivation of IL-3 for 24 h. As shown in Fig. 
5, 2-fold and 3-fold higher levels of LC-PTP mRNA were ob- 
served in the Lck-transfectants and in the Raf-transfectants, 
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Fig. 3. Effects of various reagents on induction of LC-PTP mRNA in BAF-B03 (F7) cells. F7 cells were treated with the indicated reagents 0.5 h 
prior to the stimulation of IL-2 (400 U/ml) for 3 h. RNAs were extracted from the cells which received no treatment as a negative control (Control) 
and the cells stimulated with IL-2 alone as a positive control (No inhibition). Northern blot analyses were performed with 10/Jg of total RNA/lane 
which was hybridized with a 32p-labeled LC-PTP or c-myc probe. The ribosomal RNAs are shown for relative amounts of total RNA loaded and 
their quality. 
respectively, compared to Neo-control cells. Similar results 
were obtained in the transfectants without deprivation of IL-3. 
4. Discussion 
LC-PTP is one of the early-response g ne products that is 
produced in IL-2-stimulated lymphoid cells. In this study, we 
demonstrated that expression of the LC-PTP gene and its prod- 
uct was increased upon IL-2 stimulation of an IL-3-dependent 
BAF-B03 transfectant, F7, in which a functional IL-2R was 
reconstituted byintroduction of the IL-2Rfl (Fig. 1). The kinet- 
ics of the IL-2-induced LC-PTP gene expression was increased 
within 3 h after the stimulation, peaked at 9 h and continued 
for at least 12 h. Since LC-PTP was also induced by stimulation 
of F7 cells with IL-3 (Fig. 4), expression of this phosphatase 
LC-PTP was assumed to be mediated by a common intracellu- 
lar signaling pathway that is shared by IL-2 and IL-3. 
Two distinct functional subdomains have been identified 
within the cytoplasmic domain of the fl subunits of IL-2R. The 
membrane proximal, the serine-rich region of IL-2Rfl is essen- 
tial for activation of JAK-family PTKs [21] and Src-family Syk 
[22] as well as for c-myc gene induction. On the other hand, the 
membrane distal, the acidic region of IL-2R,fl is crucial for 
activation of Src-family PTKs and for c-fos and c-jun gene 
induction [23]. To determine the functional subdomain of the 
IL-2Rfl involved in the LC-PTP gene induction, we examined 
the LC-PTP gene induction in two BAF-B03 transfectants ex- 
pressing mutant IL-2Rfls. $25 and A15 cells express IL-2R,8 
lacking the serine-rich and the acidic regions, respectively. 
Stimulation of $25 cells with IL-2 failed to induce the expres- 
sion of both c-myc and LC-PTP genes. Though c-myc gene 
expression was induced in A15 cells, LC-PTP gene was not 
induced (Fig. 2A). Thus, LC-PTP gene expression appears to 
be mediated by both the serine-rich and acidic regions of the 
IL-2Rfl, which is distinct from c-myc gene expression. 
In order to probe the intracellular signaling pathways 
through which LC-PTP expression is regulated, the possible 
involvement of PTK-dependent, cAMP-dependent, and cal- 
cium/calmodulin-dependent mechanisms were examined by 
using various pharmacological inhibitors. In the presence of 
tyrosine kinase inhibitors uch as ST638 and genistein, IL-2- 
stimulated increases in LC-PTP mRNA elevation was almost 
completely abolished. In contrast, LC-PTP expression was not 
affected by KN-62, H-89, or FK506, suggesting involvements 
of the calcium/calmodulin-dependent protein kinase II, cAMP- 
dependent protein kinase, and calcium/calmodulin-dependent 
protein phosphatase PP2B are marginal, if any (Fig. 3). Thus 
1L-2-induced LC-PTP gene expression presumably required the 
activation of some tyrosine kinase(s) or an imbalance in the 
dephosphorylation f protein on tyrosine by a phosphatase. 
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Fig. 4. LC-PTP mRNA induction by IL-3. After 24 h deprival of IL-3, 
F7 cells were treated with the indicated reagents 0.5 h prior to the 
addition of 10% WEHI-3B cells containing murine IL-3 and total RNA 
was extracted from the cells at 3 h incubation. RNA was also extracted 
from the cells which received nothing as a negative control (Control) 
and the cells stimulated with IL-3 alone as a positive control (IL-3). 
Northern blot analyses (10 ¢tg of total RNA/lane) were performed with 
hybridizing to a 32p-labeled LC-PTP probe. The ribosomal RNAs are 
shown for relative amounts of total RNA loaded and their quality. 
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Activation of Src-family PTKs, such as Lck, Fyn, and Lyn 
occurs during IL-2 and IL-3 signaling [24-26]. As a down- 
stream signaling molecule of the PTKs, an SH2-containing 
adapter protein SHC becomes tyrosine phosphorylated, then 
recruiting GRB2/SOS complexes to the plasma membrane, 
which has a GDP/GTP exchange activity for small G-protein 
RAS. The GTP-bound form of p21-Ras can then physically 
interact with the serine/threonine kinase Raf-1, which in turn 
activates the mitogen-activated protein (MAP) kinase cascade, 
following by c-fos gene induction. Since IL-2-induced c-fos gene 
expression also requires both the serine-rich and acidic regions 
of the IL-2Rfl, the Lck-mediated signaling pathway rather than 
the JAK pathway may be involved in the regulation of LC-PTP 
gene expression. Consistent with this hypothesis, overexpres- 
sions of activated-Lck or Raf-1 kinases in 32D cells resulted in 
the higher levels of LC-PTP mRNA accumulation than in 32D 
cells transfected with a control vector (Fig. 5). These results 
imply that IL-2-induced LC-PTP gene expression might be 
mediated through the signaling pathway that involves Lck, Ras 
and Raf-1. 
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Fig. 5. High levels of LC-PTP mRNA expression i  32D transfectants with overexpression f mutant LCK or mutant RAF. 32D cells transfected 
with mutant lck cDNA (Lck), mutant rafcDNA (Raf), or vector alone (Neo) were deprived of IL-3 for 24 h, and total RNA was extracted from 
the cells. 10 ,ug of total RNA were subjected to electrophoresis and transferred to nitrocellulose filters, followed by hybridization to a 32P-labeled 
LC-PTP probe. Ribosomal RNAs visualized by ethidium bromide are shown in bottom. Similar results were obtained in the transfectants without 
IL-3 starvation. The LC-PTP mRNA expressions normalized for their RNA amount analyzed by densitometry are measured by Bio-Imaging 
Analyzer, and their relative levels are shown in the right of the data. 
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Although the functional consequence of LC-PTP expression 
in IL-2 signaling remains to be determined, our data indicates 
the possible involvement in IL-2 signaling. It has been shown 
that Lck-mediated signaling has a crucial role in cell-mediated 
cytotoxic function of T-cells [27], and activation of Src-family 
PTKs in lymphoid cells or myeloid cells. It is possible therefore 
that LC-PTP may participate in the regulation of these cellular 
responses which have been functionally linked to Src-family 
kinases in lymphokine-dependent hematolymphoid cells. In ad- 
dition, it has recently been demonstrated that p56 l~k PTK is 
involved in IL-2-induced cell proliferation [28]. As shown in 
Fig. 2B and in our previous report [7], the rate of cell growth 
is slightly delayed in A15 cells in comparison with F7 cells. This 
may be reflected by the disruption of p561ok activation, which 
shuts off the LC-PTP mRNA induction. Thus, the increase of 
LC-PTP expression may also be involved in IL-2-induced cell 
proliferation. 
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